T1	Entity 0 5	FGFR2
T2	SNP 11 15	SNPs
R1	SNP_coupled_gene Arg1:T2 Arg2:T1	
T3	Association 37 41	risk
E1	Association:T3 bc:T4 snp_int:T2
T4	Cancer 23 36	breast cancer
T5	Effect_Type 45 55	augmenting
T6	Patho_physiology 56 80	oestrogen responsiveness
E2	Patho_physiology:T6 Agent:T2
R2	Effect_type_marker Arg1:E2 Arg2:T5	
A1	Effect_Type E2 Increase
T8	Entity 86 121	fibroblast growth factor receptor 2
T11	Spec 887 899	hypothesized
T12	SNP 905 918	risk variants
T13	Effect_Type 926 932	reduce
T14	Gene_Regulation 939 949	expression
E3	Gene_Regulation:T14 Theme:T15 Agent:T12
T15	Entity 933 938	FGFR2
A2	Effect_Type E3 Decrease
R5	Effect_type_marker Arg1:E3 Arg2:T13	
R6	Speculation_marker Arg1:E3 Arg2:T11	
T16	Patho_physiology 965 975	signalling
E4	Patho_physiology:T16 Agent:T12 Theme:T15
A3	Effect_Type E4 Decrease
R7	Effect_type_marker Arg1:E4 Arg2:T13	
R8	Speculation_marker Arg1:E4 Arg2:T11	
R9	SNP_coupled_gene Arg1:T12 Arg2:T15	
T17	SNP 1085 1094	rs2981578
T18	SNP 1096 1106	rs35054928
T19	SNP 1111 1121	rs45631563
T20	Entity 1067 1072	FGFR2
R10	SNP_coupled_gene Arg1:T17 Arg2:T20	
R11	SNP_coupled_gene Arg1:T18 Arg2:T20	
R12	SNP_coupled_gene Arg1:T19 Arg2:T20	
T21	Interaction 1039 1050	independent
E5	Interaction:T21 Entity:T17 Entity2:T18 Entity3:T19
T22	Neg 1039 1050	independent
R13	Negation_marker Arg1:E5 Arg2:T22	
T25	Entity 1221 1254	transcriptional silencer elements
R15	SNP_location Arg1:T17 Arg2:T25	
R16	SNP_location Arg1:T18 Arg2:T25	
R17	SNP_location Arg1:T19 Arg2:T25	
T26	Entity 1294 1306	risk alleles
R18	SNP_allele Arg1:T17 Arg2:T26	
R19	SNP_allele Arg1:T18 Arg2:T26	
R20	SNP_allele Arg1:T19 Arg2:T26	
T27	Effect_Type 1307 1314	augment
T28	Entity 1067 1072;1315 1323	FGFR2 silencer
T29	Gene_Regulation 1324 1332	activity
E6	Gene_Regulation:T29 Theme:T28 Agent:E5
A4	Effect_Type E6 Increase
R21	Effect_type_marker Arg1:E6 Arg2:T27	
T30	SNP 1350 1363	risk variants
R22	Member Arg1:T30 Arg2:T17	
R23	Member Arg1:T30 Arg2:T18	
R24	Member Arg1:T30 Arg2:T19	
T31	Effect_Type 1375 1380	lower
T32	Gene_Regulation 1387 1397	expression
E7	Gene_Regulation:T32 Theme:T33 Agent:T30
T33	Entity 1381 1386	FGFR2
A5	Effect_Type E7 Decrease
R25	Effect_type_marker Arg1:E7 Arg2:T31	
T34	Effect_Type 1402 1411	increased
T35	Patho_physiology 1422 1436	responsiveness
E8	Patho_physiology:T35 Theme:T36 Agent:T30
T36	Entity 1412 1421	oestrogen
R26	Effect_type_marker Arg1:E8 Arg2:T34	
A6	Effect_Type E8 Increase
T37	Spec 1446 1453	propose
T38	Association 1526 1530	risk
E9	Association:T38 bc:T40 snp_int:T30
T39	Effect_Type 1502 1511	increased
T40	Cancer 1512 1525	breast cancer
A7	Effect_Type E9 Increase
R27	Effect_type_marker Arg1:E9 Arg2:T39	
R28	Speculation_marker Arg1:E9 Arg2:T37	
T41	Patho_physiology 1565 1573	exposure
E10	Patho_physiology:T41 Theme:T42 Agent:T30
T42	Entity 1555 1564	oestrogen
R3	Equiv Arg1:T1 Arg2:T8	
